Eckert Anne, Keil Uta, Scherping Isabel, Hauptmann Susanne, Müller Walter E
Department of Pharmacology, Biocenter, University of Frankfurt, Germany.
Ann N Y Acad Sci. 2005 Nov;1056:474-85. doi: 10.1196/annals.1352.023.
Ginkgo biloba extract EGb 761 has been used for many years to treat age-related cognitive disorders including Alzheimer's disease. EGb 761 given shortly after initiating mitochondrial damage by sodium nitroprusside (nitric oxide donor) improved the mitochondrial membrane potential of PC12 cells significantly and dose dependently. Under these conditions, EGb 761 also reversed the decrease in ATP production. In addition, similar protection against oxidative damage was found in dissociated brain cells and isolated brain mitochondria after in vitro or in vivo treatment with EGb 761. Moreover, PC12 cells bearing an Alzheimer's disease-related mutation in the amyloid precursor protein, which leads to enhanced beta amyloid production, showed greater benefit from treatment with EGb 761 than did control cells. Taken together, our findings clearly show stabilization and protection of mitochondrial function as a specific and very sensitive property of EGb 761 at therapeutically relevant doses.
银杏叶提取物EGb 761多年来一直用于治疗包括阿尔茨海默病在内的与年龄相关的认知障碍。在用硝普钠(一氧化氮供体)引发线粒体损伤后不久给予EGb 761,可显著且剂量依赖性地改善PC12细胞的线粒体膜电位。在这些条件下,EGb 761还逆转了ATP生成的减少。此外,在体外或体内用EGb 761处理后,在解离的脑细胞和分离的脑线粒体中也发现了类似的抗氧化损伤保护作用。此外,淀粉样前体蛋白携带与阿尔茨海默病相关突变(导致β淀粉样蛋白生成增加)的PC12细胞,与对照细胞相比,用EGb 761治疗显示出更大的益处。综上所述,我们的研究结果清楚地表明,在治疗相关剂量下,稳定和保护线粒体功能是EGb 761的一种特异性且非常敏感的特性。